Navigation Links
Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin,Emerging Growth Conference

BETHESDA, Md., July 05, 2007 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, today announced that Dr. Christian Itin, President and Chief Executive Officer of Micromet, Inc., will present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference in New York on Thursday, July 12, 2007 at 10:00am, eastern.

A webcast of Dr. Itin's remarks will be available live. You can access the webcast at: www.micromet-inc.com. An archived version of the remarks will also be available through the Company's web site for a limited time following the conference.

About Micromet, Inc. (www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases. Two product candidates are currently in clinical trials. MT103/MEDI-538, which is the first product candidate based on Micromet's novel BiTE(R) product development platform, is being evaluated in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, widely recognized as the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant human monoclonal antibody which targets EpCAM expressing tumors, has completed two phase 2a clinical trials, one in patients with breast cancer and the other in patients with prostate cancer. In addition, a phase 1b trial evaluating the safety and tolerability of MT201 in combination with docetaxel is currently ongoing in patients with metastatic breast cancer. Micromet has established collaborations w
'"/>




Page: 1 2

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/20/2009)... Nov. 20 ,, Reportlinker.com a...lable in its catalogue. ,, India Medical Equip... http://www.reportlinker.com/p0164658/India-Medic....html#utm_source=prnewswire&utm_medium=pr&..., India Medical Equipment Market Analysis and Fore...
(Date:11/20/2009).... and LONDON, Nov. 20 Bo...nnounced that it has received 510(k) clearance fro...CE Mark approval to market its WallFlex® Full...lignant esophageal strictures (obstructions) cause...ectable esophageal cancer. ,, (Photo: http:/...
(Date:11/20/2009)..., N.J., Nov. 20 BD (Bect...nounced the completion of its acquisition of Handy...at develops and manufactures molecular diagnostic ..., BD and HandyLab announced an exclusive agreement...ays on the HandyLab Jaguar(TM) platform, the first...
Breaking Medicine Technology:Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Changing Paradigms in Hereditary Angioedema 3A A Focus on Timely Diagnosis and New Therapies 51238 1Changing Paradigms in Hereditary Angioedema 3A A Focus on Timely Diagnosis and New Therapies 51238 2Acupuncture Exercise May Ease Polycystic Ovarian Syndrome 51236 1Acupuncture Exercise May Ease Polycystic Ovarian Syndrome 51236 2Cardiac CT is more cost effective when managing low risk patients with chest pain 51233 1
...t Ventures Leads Investment in Lutonix to Fund Hum... Inc., today announced the,close of a $20 million ...nis Wahr, M.D. and Lixiao Wang PhD, Lutonix is a m...nd commercialization of drug coated balloon,angiop...of coronary and,peripheral artery stenosis caused ...
...im also achieved high eradication rates for the mo...tant Staphylococcus aureus (MRSA), REINACH, Switz...d the combined results from two pivotal Phase III,...e on Antimicrobial Agents,and Chemotherapy (ICAAC)...h,annual meeting in Washington, DC. In these studi...
Other Medicine Technology:Lutonix Inc. Announces $20 Million Series B Financing 2Lutonix Inc. Announces $20 Million Series B Financing 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 2Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 3Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 4Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 5Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 6Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections 7
(Date:11/20/2009)...re-USNewswire/ -- The American Academy of Actuari...orm legislation released this week to contain stro...ual coverage mandate. The actuaries said that an e...erse selection stemming from more restrictive issu...The individual mandate language should be strength...
(Date:11/20/2009)...Newswire/ -- The American Dental Association (ADA)... (FDA) to establish appropriate classifications fo... about the safety of whitening products that are o...nal consultation or examination by a dentist, the ...y based tooth whitening or bleaching agents can ha...
(Date:11/20/2009)...ire-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI... Radio Reports: What Every Women Needs to Know Ab...eran journalist Perri Peltz. ,, (Logo: http:/... ) ,, Doctor Radio Reports: What Every Woman...er 21 live at 10:00 am ET on Doctor Radio , SIRIU...
(Date:11/20/2009)...las, TX, the new addition to blue sky scrubs will ...the USA. , Austin, TX (PR...dependent medical scrubs brand which focuses prima...bution of hospital uniforms and surgical scrub hat...r online boutique, the Austin, TX business has gro...
(Date:11/20/2009)...warns against the new breast cancer recommendation...Force. These guidelines may be cost-effective, but... wrong to be safe than sorry? , ...ce recommendations, published in the current issue... firestorm in the medical community. Major medical...
Breaking Medicine News(10 mins):Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3
...e public is invited to attend the annual meeting o...be held Oct. 28 and 29 in Spokane, Wash. , The me...ce policy and technology of carbon capture and sto...on procedures, energy policies, costs and opportun...
...., Oct. 16 With a combination of,charitable contr...ement,that has become its hallmark, Massachusetts ... agents nationwide are once again rallying to the ...ntion and treatment organizations,throughout the c...
... New Performance Management Study Recogni...ertical Offerings and Exceptional Customer Service...tober 16, 2008 -- Halogen Software today announce...s. Halogen was a top ranked vendor in the study, ...
... New York,s, Clay Cockrell , a licensed ...ping his patients by taking them on a stroll throu...king in the trees and the people, Cockrell helps h... Manhattan, NY (PRWEB) October 16,...
...Oct. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech,(Ca... biotechnology and,medical device research and dev...ina and the United States, today announced it has ...maceutical R&D,services collaboration., (Logo: h...
...t. 15 Extending its collaboration with,top Americ...Mohawk Group,the commercial carpeting division of ...rt campaign in support of breast cancer awareness....st breast cancer - a disease that affects one in e...
Other Medicine News:Health News:Donations, Education, and People-Power Mark MassMutual Breast Cancer Awareness Month Efforts 2Health News:Donations, Education, and People-Power Mark MassMutual Breast Cancer Awareness Month Efforts 3Health News:Donations, Education, and People-Power Mark MassMutual Breast Cancer Awareness Month Efforts 4Health News:Bersin & Associates Identifies Halogen Software as a Market Leader 2Health News:Bersin & Associates Identifies Halogen Software as a Market Leader 3Health News:Bersin & Associates Identifies Halogen Software as a Market Leader 4Health News:New Method of Therapy Takes Patients Out of the Clinic and Into the Park 2Health News:WuXi PharmaTech Expands Collaboration for Fully Integrated Services 2Health News:Stronger Together: The Mohawk Group Supports Breast Cancer Awareness with T-Shirts Designed by Todd Oldham, Proceeds to Benefit Susan G. Komen 2
...the M3,Marco introduces 3 automated products in ...er. By combining automatic refraction, keratometry...ile providing the accurate measurements you have c... valuable space, the 3-D auto-tracking (x, y, z) a...
...eter with a Lexan®inner calibrated flow tube h...nufacturing defects. A wide range of configuration... with all popular inlet connections, a 50 psi auxi...s. Our extra large knob coupled with a fine thread...
...eter with a Lexan®inner calibrated flow tube h...nufacturing defects. A wide range of configuration... with all popular inlet connections, a 50 psi auxi...s. Our extra large knob coupled with a fine thread...
...es of time-tested Timeter® Classic Flowmeters ...s of care providers and patients alike. You can se...manship. You can see it in the performance, year a... hand-crafted and engineered to the highest standa...
Medicine Products: